Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
BATM hopes for summer launch of new coronavirus home testing kits

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
A new diagnostic home testing kit for the coronavirus could be ready within three to four months, according to one specialist equipment manufacturer.
AIM-quoted BATM Advanced Communications (BVC:AIM), a medical equipment designer based in Israel, has gone into partnership with life sciences firm Novamed for the project. The company is hopeful of launching the testing kits by early summer, once CE certification has been secured, giving thousands of households the ability to check for signs of the coronavirus at home.
‘We recognised the necessity for an easy-to-use and reliable test that can be done at home to help reduce the pressure on the already-congested hospitals and minimise patient exposure,’ said
Dr Zvi Marom, chief executive officer of BATM.
Shortages of high-quality coronavirus testing equipment
have been reported across the NHS and healthcare services around the world.
The news follows last month’s announcement of new coronavirus diagnostic equipment designed for use in medical facilities. Clinical tests have shown an ‘excellent performance’ of the kit’s ability to diagnose the coronavirus within an hour using real-time polymerase chain reaction, a widely-used technique in molecular biology. Shipments of the diagnostic kit, designed by Rome-based Adaltis, have now started.
‘We are clearly very encouraged about ongoing news flow in the Bio-Med business as the company now shows evident progress towards developing a COVID-19 testing kit,’ said Stifel analyst Luke Holbrook.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.
Our website uses cookies to give you a better browsing experience.
You can choose to accept all cookies, or control which we use by clicking 'Manage cookies'. To learn more, read our cookie policy.